RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA
Clinical trials for RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA explained in plain language.
Never miss a new study
Get alerted when new RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA trials appear
Sign up with your email to follow new studies for RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to speed healing for fragile skin disease
Disease control Recruiting nowThis study is testing whether adding IV IgG (intravenous immunoglobulin) to an existing gene therapy (VYJUVEK) helps wounds heal faster and better in people with recessive dystrophic epidermolysis bullosa (RDEB). It will enroll 8 participants who already have significant blisteri…
Matched conditions: RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA
Phase: PHASE1, PHASE2 • Sponsor: M. Peter Marinkovich • Aim: Disease control
Last updated Apr 04, 2026 06:50 UTC
-
New eye drop trial aims to soothe painful scratches in 'Butterfly Skin' disease
Disease control Recruiting nowThis study is testing whether an investigational eye drop called KB803 can safely reduce the frequency and pain of corneal abrasions (scratches on the eye's surface) in people with dystrophic epidermolysis bullosa (DEB), a rare genetic skin disorder. Participants will use either …
Matched conditions: RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA
Phase: PHASE3 • Sponsor: Krystal Biotech, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Scientists grow 'Permanent' Gene-Fixed skin to heal devastating wounds
Disease control Recruiting nowThis study is testing a new, lab-grown skin graft for people with Recessive Dystrophic Epidermolysis Bullosa (RDEB), a painful genetic condition that causes fragile, blistering skin. The graft is made from a patient's own skin cells, which are genetically corrected in a lab to pr…
Matched conditions: RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA
Phase: PHASE1, PHASE2 • Sponsor: CHU de Quebec-Universite Laval • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC